Last Close
34.67 $
Jul 8, 26
Market Cap
3.5 B $
Q1 2026 (TTM)
52-Week Range
%-12.0
%71.9
-0.32
-0.27
%-16.3
-%55.4
1M
+60.6%
3M
+49.8%
6M
+43.3%
YTD
+50.7%
1Y
-12.0%
3Y
-22.2%
Returns are computed from split-adjusted closes; dividends are not included.
Stock and gold/silver returns are in USD (metals converted into the stock's currency). The S&P 500 index is measured in its own currency.
RARE last closed at 34.67 $ (Jul 8, 26). Price data is refreshed after every trading day.
Ultragenyx (RARE) has a market capitalization of approximately 3.5 B $ as of the latest reported period.
Key peers of Ultragenyx include TELIX Pharmaceuticals Ltd, Mesoblast Ltd, CSL Ltd. A detailed metric comparison is available on the Peers tab.
Data on this page refreshes once per day. Price data as of Jul 8, 26. This content is for informational purposes only and is not investment advice.